维普期刊资源整合服务平台（V6.5）

维普中文期刊产品整合服务

12篇 您的检索式：作者名="Bosserman L"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

		题名	作者	年代	出处	被引量
	1	A 7-deaza-adenosine analog is a potent and selective inhibitor of hepatitis C virus replication with excellent pharmacokinetic properties显示文摘	Olsen D B Eldrup AB Bartholomew L Bhat B Bosserman M R Ceccacci A Colwell L F Fay J F Flores O A Getty K L Grobler J A LaFemina R L Markel E J Migliaccio G Prhavc M Stahlhut M W Tomassini J E MacCoss M Hazuda D J Carroll S S		0，，10：	1
	2	Fourteen -day CHOP supported with granulocyte colony - stimulating factor in patients with aggressive non - Hodgkin' s Lymphoma: results of a phase Ⅱ study显示文摘	Gregory SA Case DC Jr Bosserman L	2003	Clin Lymph2003，4，2：	1
	3	Denosumab treatment of prostate cancer with bone metastases and increased urine N-te- lopeptide levels after therapy with intravenous bisphosphonares: results of a randomized phase II trial 显示文摘	Fizazi K Bosserman L Gao G	2009	J Urol2009，182，2：	1
	4	Phase Ⅱ study evaluating lapatinib in combination with nab-paclitaxel in HER2-overexpressing metastatic breast cancer patients who have received no more than one prior chemotherapeutic regimen显示文摘	Yardley DA Hart L Bosserman L	2013	Breast Cancer Res Treat2013，137，2：	1
	5	Four teenday CHOP supported with Granulocyte colonystimulating factor in patients with aggressive non Hodgkin's lymphoma results of a phase Ⅱ study显示文摘	Gregory SA Case DC Bosserman L	2003	Clin Lymphoma2003，4，：	1
	6	Transfusion-associated babesiosis in the United States: a description of cases显示文摘	Herwaldt B L Linden J V Bosserman E Young C Olkowska D Wilson M	2011	Ann Intern Med2011，155，：	1
	7	Zoledronic acid effectively prevents aromatase inhibitor-associated bone loss in postmenopausal women with early breast cancer receiving adjuvant letrozole:Z-FAST study 36-month follow-up results显示文摘	Brufsky A Bosserman L Caradonna R	2009	Clin Breast Cancer2009，9，2：	1
	8	Four teen-day CHOP supported with granulocyte colonystimulating factor in patients with aggressive nonHodgkin' s lymphoma:results of a phase Ⅱ study显示文摘	Gregory SA Case DC Bosserman L	2003	Clin Lymphoma2003，4，：	1
	9	Fourteen-Day CHOP Supported with Granulocyte Colony-Stimulating Factor in Patients with Aggressive Non-Hodgkin's Lymphoma:Results of a Phase Ⅱ Study显示文摘	Gregory SA Case DC Jr Bosserman L	2003	Clin Lymph2003，4，2：	1
	10	Phase II study evaluating lapatinib in combination with nab-paclitaxel in HER2-overexpressing metastatic breast cancer patients who have received no more than one prior chemotherapeu- tic regimen显示文摘	Yardley DA Hart L Bosserman L	2013	Breast Cancer Res Treat2013，137，2：	1
	11	Fourteen-Day CHOP Supported with Granulocyte Colony-Stimulating Factor in Patients with Aggressive Non-Hodgkin's Lymphoma,Results of a Phase Ⅱ Study显示文摘	Gregory SA Case DC Jr Bosserman L	2003	Clin Lymph2003，4，2：	1
	12	Phaes 1/ study evaluating lapatinib in combination with nab-paclitaxel in HER2-overexpressing metastatic breast cancer patients who have received no more than one prior chemotherapeutic regimen显示文摘	Yard/ey DA Hart L Bosserman L	2013	Breast Cancer Res Treat2013，137，45：	1

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

goolge学术搜索-维普

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1　渝公网安备 50019002500403号　违法和不良信息举报中心

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费